IRIS
TOMASSINI, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.219
AS - Asia 1.876
EU - Europa 1.067
SA - Sud America 390
AF - Africa 35
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.601
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.154
SG - Singapore 1.111
CN - Cina 389
BR - Brasile 322
IE - Irlanda 272
IT - Italia 257
VN - Vietnam 146
DE - Germania 96
GB - Regno Unito 89
RU - Federazione Russa 85
SE - Svezia 82
HK - Hong Kong 53
IN - India 36
CA - Canada 34
FI - Finlandia 33
AR - Argentina 29
AT - Austria 23
JP - Giappone 22
BD - Bangladesh 21
KR - Corea 21
ES - Italia 19
MX - Messico 19
FR - Francia 18
UA - Ucraina 18
PL - Polonia 15
ZA - Sudafrica 15
TR - Turchia 14
PK - Pakistan 11
AU - Australia 10
BE - Belgio 9
CZ - Repubblica Ceca 9
IQ - Iraq 9
NL - Olanda 9
EC - Ecuador 8
ID - Indonesia 8
IR - Iran 8
PY - Paraguay 8
RO - Romania 7
VE - Venezuela 7
CL - Cile 6
LT - Lituania 5
PA - Panama 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
CO - Colombia 4
KE - Kenya 4
UZ - Uzbekistan 4
CH - Svizzera 3
EG - Egitto 3
JM - Giamaica 3
TN - Tunisia 3
AZ - Azerbaigian 2
DZ - Algeria 2
EU - Europa 2
GA - Gabon 2
IL - Israele 2
JO - Giordania 2
KZ - Kazakistan 2
MA - Marocco 2
MD - Moldavia 2
OM - Oman 2
PT - Portogallo 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AL - Albania 1
AO - Angola 1
BN - Brunei Darussalam 1
DK - Danimarca 1
EE - Estonia 1
HN - Honduras 1
HU - Ungheria 1
KW - Kuwait 1
LB - Libano 1
MC - Monaco 1
ME - Montenegro 1
ML - Mali 1
MN - Mongolia 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TG - Togo 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.601
Salva come PNG Salva come JPEG
Città #
Dallas 926
Singapore 861
Chandler 286
Dublin 268
Ashburn 225
Santa Clara 161
Beijing 135
The Dalles 100
Los Angeles 94
Jacksonville 84
Princeton 82
Hong Kong 53
Hefei 51
Tongling 48
Munich 44
Buffalo 43
Ho Chi Minh City 42
New York 42
Altamura 41
São Paulo 34
Dong Ket 33
Redondo Beach 31
Wilmington 29
Nuremberg 28
Rome 24
Seoul 21
Tokyo 21
Washington 21
London 20
Seattle 19
Denver 18
Brooklyn 17
Chieti 17
Boston 16
Hanoi 16
Pescara 16
Ann Arbor 15
Houston 15
Helsinki 14
Milan 14
Romola 14
Teramo 14
Chicago 13
Montreal 13
Chennai 12
Falls Church 12
Warsaw 12
Boardman 11
Johannesburg 11
Orem 11
Stockholm 11
Atlanta 10
Camerino 10
Lappeenranta 10
Moscow 10
Phoenix 10
Brussels 9
Campinas 9
Fairfield 8
Frankfurt am Main 8
Rio de Janeiro 8
Southend 8
Tehran 8
Vienna 8
Castignano 7
Haiphong 7
Mexico City 7
Poplar 7
Saint Petersburg 7
Sydney 7
Toronto 7
Turku 7
Woodbridge 7
Cardiff 6
Da Nang 6
Dhaka 6
Düsseldorf 6
Mumbai 6
Nanchang 6
Norwalk 6
Porto Alegre 6
Santander 6
Asunción 5
Baghdad 5
Belo Horizonte 5
Biên Hòa 5
Brasília 5
Istanbul 5
Naples 5
Oxford 5
Pune 5
San Francisco 5
Silvi 5
Brno 4
Carney 4
Charlotte 4
Edinburgh 4
Goiânia 4
Guangzhou 4
Izmir 4
Totale 4.475
Salva come PNG Salva come JPEG
Nome #
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 122
A flow-diffusion model of oxygen transport for quantitative mapping of cerebral metabolic rate of oxygen (CMRO2) with single gas calibrated fMRI 121
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study 118
Contribution of metabolomics to multiple sclerosis diagnosis, prognosis and treatment 113
Comparing MRI metrics to quantify white matter microstructural damage in multiple sclerosis 112
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia 111
A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy 104
Cerebrovascular reactivity in multiple sclerosis is restored with reduced inflammation during immunomodulation 101
Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients with Multiple Sclerosis 101
Testosterone amplifies excitotoxic damage of cultured oligodendrocytes. 100
Neuroplasticity and motor rehabilitation in multiple sclerosis 99
Modelling the natural history of primary progressive multiple sclerosis 98
Assessment of the Effects of Aerobic Fitness on Cerebrovascular Function in Young Adults Using Multiple Inversion Time Arterial Spin Labeling MRI 98
Tractography in the presence of multiple sclerosis lesions 97
Brain morphometry in Multiple Sclerosis 95
Dual-calibrated fMRI measurement of absolute cerebral metabolic rate of oxygen consumption and effective oxygen diffusivity 94
Pathophysiology of multiple sclerosis damage and repair: Linking cerebral hypoperfusion to the development of irreversible tissue loss in multiple sclerosis using magnetic resonance imaging 93
Oral contraceptives combined with interferon b in multiple sclerosis 92
Relationship between Prolactin Plasma Levels and White Matter Volume in Women with Multiple Sclerosis 91
The effect of inflammation and its reduction on brain plasticity in multiple sclerosis: MRI evidence 89
Neurovascular Coupling During Visual Stimulation in Multiple Sclerosis: A MEG-fMRI Study 89
Neurological update: MOG antibody disease 87
A frequency-domain machine learning method for dual-calibrated fMRI mapping of oxygen extraction fraction (OEF) and cerebral metabolic rate of oxygen consumption (CMRO 2) 87
Breath-hold BOLD fMRI without CO2 sampling enables estimation of venous cerebral blood volume: potential use in normalization of stimulus-evoked BOLD fMRI data 85
Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases 85
Predicting the profile of increasing disability in multiple sclerosis 84
Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS 84
Cerebral Metabolic Changes During Visuomotor Adaptation Assessed Using Quantitative fMRI 83
How common is truly benign MS in a UK population? 82
A 6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with Interferon-beta 81
FACS-Proteomics strategy toward extracellular vesicles single-phenotype characterization in biological fluids: exploring the role of leukocyte-derived EVs in multiple sclerosis 81
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study 79
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis 78
Medical education and MS: getting the training right 77
Informing MS patients on treatment options: a consensus on the process of consent taking 77
Changes of brain parenchyma free water fraction reflect tissue damage and impaired processing speed in multiple sclerosis 76
Site-specific clinical disease onset in multiple sclerosis 76
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study 76
Effect on Cognition of Estroprogestins Combined with Interferon Beta in Multiple Sclerosis: Analysis of Secondary Outcomes from a Randomised Controlled Trial 75
Exergames for balance dysfunction in neurological disability: a meta-analysis with meta-regression 74
Lessons from immunotherapies in multiple sclerosis 73
Impact of the 2017 revisions to McDonald criteria on the diagnosis of multiple sclerosis 73
Guillain−Barré syndrome and SARS-CoV-2 infection: a systematic review and meta-analysis on a debated issue and evidence for the ‘Italian factor’ 72
Age-related changes in grey and white matter structure throughout adulthood 71
Impaired Functional Connectivity Unmasked by Simple Repetitive Motor Task in Early Relapsing-Remitting Multiple Sclerosis 71
Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems group 71
Diffusion-weighted imaging tractography-based parcellation of the human lateral premotor cortex identifies dorsal and ventral subregions with anatomical and functional specializations 71
Mechanisms of Network Changes in Cognitive Impairment in Multiple Sclerosis 70
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 67
Alexithymia in multiple sclerosis: relationship with fatigue and depression 66
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis 64
Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment 64
The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis 63
Neuroplasticity and functional recovery in multiple sclerosis 63
Corrigendum: A Frequency-Domain Machine Learning Method for Dual-Calibrated fMRI Mapping of Oxygen Extraction Fraction (OEF) and Cerebral Metabolic Rate of Oxygen Consumption (CMRO 2) 63
Changes in brain perfusion with training-related visuomotor improvement in MS 63
Relating brain damage to brain plasticity in patients with multiple sclerosis 62
Evidence of impaired brain activity balance after passive sensorimotor stimulation in multiple sclerosis 62
Guillain–Barré syndrome and COVID-19 vaccination: a systematic review and meta-analysis 61
Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 59
Endogenous retroviruses in multiple sclerosis: A network-based etiopathogenic model 59
Similarities and differences between multiple sclerosis and type 1 diabetes 59
Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study 58
Investigating social cognition in Multiple Sclerosis: Does Implicit Biological Motion processing affect visuo-spatial attention? 58
Diagnosis and management of multiple sclerosis: MRI in clinical practice 58
"Back to Braak": Role of Nucleus Reuniens and Subcortical Pathways in Alzheimer's Disease Progression 57
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study 57
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose 57
Predictors of training-related improvement in visuomotor performance in patients with multiple sclerosis: A behavioural and MRI study 57
Monthly corticosteroids decrease neutralizing antibodies to IFNbeta1 b: a randomized trial in multiple sclerosis 57
Neutralizing and binding antibodies to IFN-beta: relative frequency in relapsing-remitting multiple sclerosis patients treated with different IFN-beta preparations 54
Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis 54
Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial 53
Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability 53
Structural and functional bases for individual differences in motor learning 53
Neutralizing antibodies explain the poor clinical response to interferon beta in a small proportion of patients with multiple sclerosis: a retrospective study 53
Motor practice promotes increased activity in brain regions structurally disconnected after subcortical stroke 52
Preservation of motor skill learning in patients with multiple sclerosis 52
Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis 52
Model-free characterization of brain functional networks for motor sequence learning using fMRI 52
Progressive multifocal leukoencephalopathy or severe multiple sclerosis relapse following COVID-19 vaccine: a diagnostic challenge 52
'Gender gap' in multiple sclerosis: magnetic resonance imaging evidence 50
Distinct and overlapping functional zones in the cerebellum defined by resting state functional connectivity 48
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study 48
Diffusion-Weighted Imaging Tractography-Based Parcellation of the Human Parietal Cortex and Comparison with Human and Macaque Resting-State Functional Connectivity 48
Reduced brain oxygen metabolism in patients with multiple sclerosis: Evidence from dual-calibrated functional MRI 48
Relationship between emotional distress in caregivers and health status in persons with multiple sclerosis 47
A tractometry principal component analysis of white matter tract network structure and relationships with cognitive function in relapsing-remitting multiple sclerosis 46
Contemporary study of multiple sclerosis disability in South East Wales 46
Sex hormones modulate brain damage in multiple sclerosis: MRI evidence 45
Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosis 45
Multiple sclerosis lesions: insights from imaging techniques 44
Sex hormones: a role in the control of multiple sclerosis? 42
Sex hormones, brain damage and clinical course of Multiple Sclerosis 41
Post-marketing survey on clinical response to interferon beta in relapsing multiple sclerosis: the Roman experience 41
Interferon beta treatment of MS in the daily clinical setting: a 3-year post-marketing study 41
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study 36
Transverse myelitis in children and adults 35
Fate of neutralizing and binding antibodies to IFN beta in MS patients treated with IFN beta for 6 years 34
Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride 29
Totale 6.965
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.149
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.149
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021102 0 0 0 0 0 29 8 14 6 5 0 40
2021/2022209 1 1 3 3 8 12 3 37 25 5 17 94
2022/2023889 76 131 41 85 70 143 57 62 100 42 46 36
2023/2024640 52 21 55 24 32 184 116 41 15 33 14 53
2024/20252.205 120 544 421 52 47 58 76 82 192 147 161 305
2025/20262.605 334 224 1.141 528 345 33 0 0 0 0 0 0
Totale 6.986